Xilio Therapeutics

IPO

Tumor-selective Immunotherapy

Xilio Therapeutics was founded in 2016, is headquartered in Waltham, United States, lists 51–200 employees, and has $225.5M in recorded funding across 3 rounds.

Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$225.5M
Last Round
$95.0M Series CFeb 2021
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 4 investors for this company. The full record is or through the API.

About

Xilio is a clinical-stage biotechnology company developing masked immuno-oncology therapies for people living with cancer. Its biology and protein-engineering approach creates biologics that remain inactive until they reach the tumor microenvironment, where tumor-specific proteases activate them. The company is advancing preclinical and clinical programs for masked multi-specific therapies.

Summary

Xilio Therapeutics is a Biotech company based in Waltham, United States, founded in 2016. It lists 51–200 employees. It has raised $225.5M in total across 3 rounds, most recently a $95.0M Series C round in Feb 2021. Investors include SV Health Investors, Coastlands Capital and Frazier Life Sciences.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOOct 2021
$117.6M

Sign up to see all 4 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Xilio Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/xilio-therapeutics"><img src="https://indexed.vc/api/badge/company/xilio-therapeutics" alt="Xilio Therapeutics on Indexed.vc" width="260" height="76" /></a>